(Q31120359)

29 June 2017

1 reference

title

New high-technology products for the treatment of haemophilia (English)

1 reference

29 June 2017

0 references

Pipe SW

1

1 reference

29 June 2017

Saint-Remy JM

series ordinal

2

1 reference

29 June 2017

Walsh CE

series ordinal

3

1 reference

29 June 2017

publication date

1 October 2004

1 reference

29 June 2017

1 reference

29 June 2017

volume

10 Suppl 4

1 reference

29 June 2017

page(s)

55-63

1 reference

Coagulation factors with improved properties for hemophilia gene therapy

29 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00996.X

Expression of factor VIII in recombinant and transgenic systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00996.X

A 110-amino acid region within the A1-domain of coagulation factor VIII inhibits secretion from mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00996.X

LMAN1 is a molecular chaperone for the secretion of coagulation factor VIII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00996.X

Bioengineering of coagulation factor VIII for improved secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00996.X

Hemophilia A mutations associated with 1-stage/2-stage activity discrepancy disrupt protein-protein interactions within the triplicated A domains of thrombin-activated factor VIIIa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00996.X

Characterization of a genetically engineered inactivation-resistant coagulation factor VIIIa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00996.X

An engineered interdomain disulfide bond stabilizes human blood coagulation factor VIIIa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00996.X

Antigen-stimulated dissociation of BCR mIg from Ig-alpha/Ig-beta: implications for receptor desensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00996.X

Two classes of germline genes both derived from the V(H)1 family direct the formation of human antibodies that recognize distinct antigenic sites in the C2 domain of factor VIII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00996.X

Structure of a factor VIII C2 domain-immunoglobulin G4kappa Fab complex: identification of an inhibitory antibody epitope on the surface of factor VIII

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00996.X

In vivo neutralization of a C2 domain-specific human anti-Factor VIII inhibitor by an anti-idiotypic antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00996.X

Peptide decoys selected by phage display block in vitro and in vivo activity of a human anti-FVIII inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00996.X

Detection and analysis of spliced chimeric mRNAs in sequence databanks

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00996.X

Spliced leader RNAs from lower eukaryotes are trans-spliced in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00996.X

Emerging clinical applications of RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00996.X

Spliceosome-mediated RNA trans-splicing as a tool for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00996.X

Messenger RNA repair and restoration of protein function by spliceosome-mediated RNA trans-splicing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00996.X

Messenger RNA reprogramming by spliceosome-mediated RNA trans-splicing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00996.X

Repair of CFTR mRNA by spliceosome-mediated RNA trans-splicing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00996.X

Phenotype correction of hemophilia A mice by spliceosome-mediated RNA trans-splicing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00996.X

Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00996.X

10.1111/J.1365-2516.2004.00996.X

21 January 2018

Identifiers

DOI

1 reference

29 June 2017

1 reference